Onward Medical NVONWRF 37 Gross Margin % is 70.60% as of Dec. 2025, which is 3% below its 10-year median of 72.51. GuruFocus rates ONWRF with a GF Score™ of 37/100 and a GF Value™ of $154.42 (Possible Value Trap). The stock has 4 warning signs investors should review. Among 735 Biotechnology companies, Onward Medical NV ranks better than 62.72% on this metric.
The historical rank and industry rank for Onward Medical NV's Gross Margin % or its related term are showing as below:
ONWRF'
s Gross Margin % Range Over the Past 10 Years
Min: -14122.12 Med: 72.51 Max: 90.39
Current: 72.51
During the past 9 years, the highestGross Margin % of Onward Medical NV was 90.39%. The lowest was -14122.12%. And the median was 72.51%.
ONWRF's Gross Margin % is ranked better than 62.72% of 735
companies
in the Biotechnology industry
Industry Median: 60.9
vs ONWRF: 72.51
Onward Medical NV had a gross margin of 70.60% for the quarter that ended in Dec. 2025 => Durable competitive advantage
The 5-Year average Growth Rate of Gross Margin for Onward Medical NV was 0.00% per year.
Onward Medical NV (OTCPK:ONWRF) Gross Margin % Explanation
Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.
Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %
1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key
Onward Medical NV had a gross margin of 70.60% for the quarter that ended in Dec. 2025 => Durable competitive advantage
Be Aware
If a company loses its competitive advantages, usually its gross margin declines well before its sales declines. Watching Gross Margin % and Operating Margin % closely helps avoid value trap situations.
Onward Medical NV Gross Margin % Related Terms
Onward Medical NV Gross Margin % Historical Data
* Premium members only.
The historical data trend for Onward Medical NV's Gross Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
ONWRF vs VRTX, REGN, ALNY: Gross Margin % Comparison
For the Biotechnology subindustry, Onward Medical NV's Gross Margin %, along with its competitors' market caps and Gross Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Onward Medical NV Gross Margin % vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Onward Medical NV's Gross Margin % distribution charts can be found below:
* The bar in red indicates where Onward Medical NV's Gross Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.
Onward Medical NV (ONWRF) has a Gross Margin % of 70.60% as of Dec. 2025. Gross margin is the ratio of total gross profit to net sales. View historical data on Onward Medical NV and its competitors. This is near median its historical median of 72.51. According to the industry distribution chart, Onward Medical NV ranks #274 out of 735 companies in the Biotechnology industry, placing it in the top 37.3%.
Is Onward Medical NV's Gross Margin % too high?
Onward Medical NV's current Gross Margin % of 70.60% is near median its 10-year median of 72.51. The Biotechnology industry median Gross Margin % is 60.90. Onward Medical NV's value of 70.60% is 15.9% above this industry median. Based on the distribution chart, Onward Medical NV ranks #274 out of 735 companies in the Biotechnology industry, which is above the industry midpoint. Overall, Onward Medical NV has a GF Score™ of 37/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Onward Medical NV's Gross Margin % compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Onward Medical NV ranks #274 out of 735 companies for Gross Margin %. This puts Onward Medical NV in the upper half of its industry. The industry median Gross Margin % is 60.90. Onward Medical NV's value of 70.60% is 15.9% above this benchmark. While the company's 10-year median is 72.51 vs. the industry median of 60.90, Onward Medical NV has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Gross Margin % for a Biotechnology company?
The median Gross Margin % among Biotechnology companies is 60.90, based on 735 companies in the industry. Companies in the top quartile (top 25%) have a Gross Margin % significantly above this median, while those in the bottom quartile fall well below. However, Gross Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Onward Medical NV's current Gross Margin % of 70.60% is 15.9% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Gross Margin % mean?
A high Gross Margin % can signal that a stock is expensive relative to its fundamentals. Gross margin is the ratio of total gross profit to net sales. View historical data on Onward Medical NV and its competitors. For the Biotechnology industry, the median Gross Margin % is 60.90 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Onward Medical NV's current Gross Margin % is 70.60%, which is near median its own 10-year median of 72.51. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Onward Medical NV stock overvalued right now?
Based on GuruFocus' analysis, Onward Medical NV (ONWRF) is currently considered Possible Value Trap. The stock's GF Value™ is $154.42, compared to a current price of $2.96 — trading 98.1% below its estimated fair value. The current Gross Margin % is 70.60%, which is near median its 10-year median of 72.51 and 15.9% above the Biotechnology industry median of 60.90. Onward Medical NV's overall GF Score™ is 37/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Gross Margin % calculated?
Gross Margin % is calculated from a company's financial statements. For Onward Medical NV (ONWRF), the current Gross Margin % is 70.60% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Onward Medical NV (ONWRF) Overvalued in 2026?
Based on GuruFocus' analysis, Onward Medical NV stock appears to be undervalued.
The current stock price of $2.96 is trading 98.1% below its estimated GF Value™ of $154.42.
GuruFocus considers Onward Medical NV to be Possible Value Trap.
Key valuation signals for ONWRF:
Gross Margin %: 70.60% (near median its 10-year median of 72.51)
GF Value™: $154.42 vs. price of $2.96 (98.1% below fair value)
Industry Position: 15.9% above the Biotechnology median (#274 of 735)
No single metric tells the full story. See the ONWRF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Onward Medical NV is developing and commercializing therapies to enable functional recovery for people with Spinal Cord Injury (SCI). The company's technology platforms are based on ONWARD ARC Therapy (ARC Therapy), targeted, programmed electrical stimulation of the spinal cord designed to restore movement, independence, and health in people with SCI.
37GF Score
Get the complete analysis for ONWRF
Gross Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ONWRF has been successfully added to your 
